Sotera Health Co

Sotera Health is a U.S.-based provider of sterilization, laboratory testing, and advisory services for healthcare and life-science supply chains. Its businesses include outsourced terminal sterilization and irradiation, microbiological and analytical testing, and cobalt-60 source supply and related services through Sterigenics, Nelson Labs, and Nordion.

55,5 %

6,7 %

+5,7 %

2.46

2.24

— Sotera Health Co
%
Sterilization Services55% Contract sterilization, irradiation, and validation services for medical, pharma, food, and industrial customers.
Laboratory Testing and Advisory30% Microbiological, analytical chemistry, biocompatibility, toxicology, and regulatory advisory services.
Cobalt-60 Products and Services15% Sale of Co-60 radiation sources plus installation, disposal, and related support services.

Customers are primarily medical device manufacturers, pharmaceutical companies, and other healthcare-related producers...

  • Medical device manufacturersprimary

    Buy sterilization, validation, and lab testing to meet device safety and regulatory requirements.

  • Pharmaceutical companiesprimary

    Buy microbiological testing, extractables/leachables, packaging validation, and sterilization support.

  • Food and agricultural producerssecondary

    Use irradiation services for product safety and shelf-life or contamination control.

  • Advanced commercial materials customerssecondary

    Use radiation processing for materials such as polymers, semiconductors, and gemstones.

  • Medical equipment and sterilization service providersprimary

    Buy Co-60 sources and related services for gamma irradiation and oncology applications.

Sotera Health operates globally, with customers in more than 50 countries and 62 facilities worldwide...

  • •Customers in more than 50 countries
  • •62 facilities worldwide support sterilization and testing
  • •U.S. is a major operating and regulatory center
  • •International supply chains matter for customer manufacturing sites
  • •Global operations create foreign-currency and compliance exposure

The company is investing in capacity expansion, Co-60 development, and lab growth to support demand across its three...

01
Capacity expansionmedium-term

More facility capacity supports customer demand and reduces bottlenecks in mission-critical services.

02
Co-60 supply developmentmedium-term

Reliable isotope supply is central to Nordion's product and service offering.

03
Lab growthmedium-term

Expanded testing capabilities support pharma and device customers and deepen recurring relationships.

04
Disciplined M&Along-term

Acquisitions can broaden capabilities and scale if integrated successfully.

The business is exposed to supply, regulatory, litigation, and operational risks because its services rely on hazardous...

critical

EO litigation and liability claims

Past and future claims tied to EO emissions and facility operations can create settlement and legal expense.

Scope
Former and current EO sterilization facilities
Materiality
high
high

EO and Co-60 supply disruption or price inflation

Sterilization and isotope supply are core inputs to the business and may be affected by geopolitics or sanctions.

Scope
Sterigenics and Nordion
Materiality
high
high

Regulatory compliance and approvals

Customers rely on the company to meet government and quality requirements, so failures can disrupt demand.

Scope
Sterilization and lab testing operations
Materiality
high
high

Leverage and debt covenant constraints

Debt can limit flexibility and increase sensitivity to operating or legal shocks.

Scope
Corporate capital structure
Materiality
high
medium

Foreign currency exchange volatility

The company serves customers across many countries and reports exposure to FX changes in results.

Scope
International operations
Materiality
medium
medium

Competition and substitution

Customers may shift to X-ray sterilization, alternative suppliers, or in-house testing.

Scope
Sterigenics, Nordion, Nelson Labs
Materiality
medium
Revenue recognition timing
Service revenues and product revenues can move differently by period
Litigation and contingency accruals
Can materially affect operating expense and cash outflows
Asset retirement obligations
Affects long-lived asset and liability balances
Interest rate derivatives
Affects interest expense and other comprehensive income
Goodwill and intangible impairment
Could create non-cash charges

Natera, Inc.

NTRA · Services-Medical Laboratories

Protara Therapeutics, Inc.

TARA · Biological Products, (No Diagnostic Substances)

Fortrea Holdings Inc.

FTRE · Services-Medical Laboratories

Sanara MedTech Inc.

SMTI · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Co-Diagnostics, Inc.

CODX · Surgical & Medical Instruments & Apparatus

SECTRA

SECT-B.ST · Health Care

: 29/04/2026